Sangamo Therapeutics To Host Conference Call To Review Interim Results From Phase 1/2 CHAMPIONS And EMPOWERS Studies For MPS II And MPS I
The conference call will be webcast live and can be accessed via a link on the
The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 4387585. For those unable to listen in at the designated time, a conference call replay will be available for one week following the call. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 4387585.
About the WORLDSymposium Presentations
The WORLDSymposium program includes two platform presentations from clinical trials of Sangamo's ZFN in vivo genome editing product candidates, SB-913 (MPS II) and SB-318 (MPS I):
- "CHAMPIONS: A Phase 1/2 clinical trial with dose escalation of SB-913 ZFN-mediated in vivo human genome editing for treatment of MPS II (Hunter syndrome)"
- "EMPOWERS: A Phase 1/2 clinical trial of SB-318 ZFN-mediated in vivo human genome editing for treatment of MPS I (Hurler Syndrome)"
Also at the WORLDSymposium, Sangamo is scheduled to present a poster and lead a poster discussion regarding updated mouse model data from the ST-920 liver-targeted gene therapy program for Fabry disease:
- "Liver-targeted AAV gene therapy vectors produced by a clinical scale manufacturing process result in high, continuous therapeutic levels of enzyme activity and effective substrate reduction in mouse model of Fabry disease"
View original content to download multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-to-host-conference-call-to-review-interim-results-from-phase-12-champions-and-empowers-studies-for-mps-ii-and-mps-i-300788064.html
Sangamo Therapeutics, Inc., Investors, McDavid Stilwell, 510-970-6000, x219, email@example.com; or Varant Shirvanian, 510-970-6000 x205, firstname.lastname@example.org; or Media, Aron Feingold, 510-970-6000, x421, email@example.com